Prevalence of mental disorders in acromegaly: A cross-sectional study in 81 acromegalic patients

Clinical Endocrinology

Volumn 71, Issue 5, 2009, Pages 691-701

  Sievers, Caroline ^a   Dimopoulou, Christina ^a   Pfister, Hildegard ^a   Lieb, Roselind ^a,b   Steffin, Birgit ^c   Roemmler, Josefine ^c   Schopohl, Jochen ^c   Mueller, Marion ^a   Schneider, Harald Jörn ^a,c   Ising, Marcus ^a   Wittchen, Hans Ulrich ^d   Stalla, Guenter Karl ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ADULT; ARTICLE; BEHAVIOR; COMPUTER AIDED DESIGN; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMOTION; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; INTERVIEW; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ACROMEGALY; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED;

EID: 70349687370     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03555.x     Document Type: Article

References (37)

1. Colao, A., Ferone, D., Marzullo, P. et al. (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews, 25, 102 152.
2. Marie, P (1886) Sur deux cas d'acromégalie; hypertrophie singulière non congénitale des extrémités supérieures, inférieures et céphalique. Revue Médicale de Liège, 6, 297 333.
3. Bleuler, M. (1951) The psychopathology of acromegaly. Journal of Nervous and Mental Disease, 113, 497 511.
4. Bleuler, M. (1951) Personality changes in pituitary disorders. British Medical Journal, 1, 580 581.
5. Blickenstorfer, E. (1951) [Psychiatry and genealogy of acromegaly; studies from the confines of psychopathology of endocrinology.]. Archiv für Psychiatrie und Nervenkrankheiten, vereinigt mit Zeitschrift für die gesamte Neurologie und Psychiatrie, 186, 88 122.
6. Blickenstorfer, E. (1953) [Genealogy and psychopathology of 51 acromegaly patients.]. Acta Endocrinologica, 13, 123 137.
7. Blickenstorfer, E. (1953) [Psychiatric and genealogic study of 51 cases of acromegaly.]. Schweizer Archiv für Neurologie und Psychiatrie, 71, 371 374.
8. Richert, S., Strauss, A., Fahlbusch, R. et al. (1987) [Psychopathologic symptoms and personality traits in patients with florid acromegaly]. Schweizer Archiv für Neurologie und Psychiatrie, 138, 61 86.
9. Sablowski, N., Pawlik, K., Ludecke, D.K. et al. (1986) Aspects of personality in patients with pituitary adenomas. Acta Neurochirurgica, 83, 8 11.
10. Abed, R.T., Clark, J., Elbadawy, M.H. et al. (1987) Psychiatric morbidity in acromegaly. Acta Psychiatrica Scandinavica, 75, 635 639.
11. Ezzat, S., Forster, M.J., Berchtold, P. et al. (1994) Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore), 73, 233 240.
12. Furman, K. Ezzat, S. (1998) Psychological features of acromegaly. Psychotherapy and Psychosomatics, 67, 147 153.
13. Flitsch, J., Spitzner, S. Ludecke, D.K. (2000) Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Experimental and Clinical Endocrinology and Diabetes, 108, 480 485.
14. Korali, Z., Wittchen, H.U., Pfister, H. et al. (2003) Are patients with pituitary adenomas at an increased risk of mental disorders Acta Psychiatrica Scandinavica, 107, 60 68.
15. Russo, V.C., Gluckman, P.D., Feldman, E.L. et al. (2005) The insulin-like growth factor system and its pleiotropic functions in brain. Endocrine Reviews, 26, 916 943.
16. Aberg, N.D. (2005) Growth Hormone and Insuline-like Growth Factor-I and Cellular Regeneration in the Adult Brain. Academic Press, Elsevier, MA, USA, 125 146.
17. Bondy, C.A. Cheng, C.M. (2002) Insulin-like growth factor-1 promotes neuronal glucose utilization during brain development and repair processes. International Review of Neurobiology, 51, 189 217.
18. Torres-Aleman, I., Naftolin, F. Robbins, R.J. (1990) Trophic effects of insulin-like growth factor-I on fetal rat hypothalamic cells in culture. Neuroscience, 35, 601 608.
19. Schneider, H.J., Pagotto, U. Stalla, G.K. (2003) Central effects of the somatotropic system. European Journal of Endocrinology, 149, 377 392.
20. Sievers, C., Schneider, H.J. Stalla, G.K. (2008) Insulin-like growth factor-1 in plasma and brain: regulation in health and disease. Frontiers in Bioscience, 13, 85 99.
21. Jacobi, F., Wittchen, H.U., Holting, C. et al. (2004) Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychological Medicine, 34, 597 611.
22. Jacobi, F., Wittchen, H.U., Holting, C. et al. (2002) Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey. International Journal of Methods in Psychiatric Research, 11, 1 18.
23. Giustina, A., Barkan, A., Casanueva, F.F. et al. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526 529.
24. Melmed, S., Casanueva, F., Cavagnini, F. et al. (2005) Consensus statement: medical management of acromegaly. European Journal of Endocrinology, 153, 737 740.
25. Melmed, S. (2006) Medical progress: acromegaly. New England Journal of Medicine, 355, 2558 2573.
26. Wittchen, H.U. Pfister, H. (1997) DIA-X-Interviews: Manual für Screening-Verfahren und Interview, Interviewheft Längsschnittuntersuchung (DIA-C-Lifetime), PC-Programm zur Durchführung des Interviews; Auswertprogramm. Frankfurt, Germany.
27. Harter, M., Baumeister, H., Reuter, K. et al. (2007) Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychotherapy and Psychosomatics, 76, 354 360.
28. Weitzner, M.A. (1998) Neuropsychiatry and pituitary disease: an overview. Psychotherapy and Psychosomatics, 67, 125 132.
29. Astle, F. (2007) Diabetes and depression: a review of the literature. Nursing Clinics of North America, 42, 67 78, vii.
30. Katon, W., Lin, E.H. Kroenke, K. (2007) The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry, 29, 147 155.
31. Sievers, C., Sämann, P.G., Dose, T. et al. (2009) Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary, 12, 177 185.
32. Abelson, J.L., Khan, S., Liberzon, I. et al. (2007) HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depression and Anxiety, 24, 66 76.
33. Eser, D., Schule, C., Baghai, T.C. et al. (2006) Neuroactive steroids and affective disorders. Pharmacology, Biochemistry, and Behavior, 84, 656 666.
34. Biermasz, N.R., van Thiel, S.W., Pereira, A.M. et al. (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. Journal of Clinical Endocrinology and Metabolism, 89, 5369 5376.
35. Rowles, S.V., Prieto, L., Badia, X. et al. (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. Journal of Clinical Endocrinology and Metabolism, 90, 3337 3341.
36. Weitzner, M.A., Kanfer, S. Booth-Jones, M. (2005) Apathy and pituitary disease: it has nothing to do with depression. Journal of Neuropsychiatry and Clinical Neurosciences, 17, 159 166.
37. Wittchen, H.U., Lachner, G., Wunderlich, U. et al. (1998) Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Social Psychiatry and Psychiatric Epidemiology, 33, 568 578. (Pubitemid 28477089)